October 17, 2011 in Games (E)
[prMac.com] Berlin, Germany - Good Blood! is now available on the App Store! The Serious Game provides action-packed real-time 3D gaming and combines this didactically via learning about human blood. The player moves with the flowing blood in the bloodstream. You have to differentiate between the blood cells to fight viruses and bacteria, to destroy blood clots and to simulate other incidents that occur in the blood. You learn everything that happens in a blood vessel hands-on and also with which defense mechanisms the immune system combats illnesses and heals wounds.
The real-time 3D technology offers the ideal possibility to make the complex world of the inner body visually accessible and consequently allows for a unique user experience by actually plunging into this unknown dimension. The appealing graphics, the visual and acoustic effects support the action packed plot and allow for even more game enjoyment. The border between action games and knowledge development becomes a blur and guarantees that Good Blood is equally appealing to casual gamers and to those with a thirst for knowledge alike - edutainment for everyone!
Are you courageous enough to combat deadly viruses to make a full recovery? Do you have strong nerves in this serious game to act under time pressure and reach the goal? Then this is the game for you! Go for Good Blood!
* iPhone, iPod touch, and iPad
* Requires iOS 3.2 or later
* 12.4 MB
Pricing and Availability:
Good Blood! 1.0 is only $0.99 USD (or equivalent amount in other currencies) and available worldwide exclusively through the App Store in the Games category.
Based in Berlin, Germany, Frukti GbR was founded in 2011 by Nicole Vilain and Helen Sell. The company stands for innovative development with a long standing experience in the feld of design, gaming, virtual worlds and life sciences. Copyright (C) 2011 Frukti GbR. All Rights Reserved. Apple, the Apple logo, iPhone, iPod and iPad are registered trademarks of Apple Inc. in the U.S. and/or other countries.